Inactive Provider
This provider's NPI has been deactivated on 04/12/2026. The information on this page is historical and may no longer be current.
Total Payments
$3,263
2022 Payments
$18.30
Companies
18
Transactions
138
Medicare Patients
3,143
Medicare Billing
$167,009
Payment Breakdown by Category
Food & Beverage$3,147 (96.4%)
Gifts$116.24 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,147 | 128 | 96.4% |
| Gift | $116.24 | 10 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CIPLA USA INC. | $1,302 | 1 | $0 (2020) |
| Astellas Pharma US Inc | $1,166 | 84 | $0 (2021) |
| ABBVIE INC. | $187.73 | 14 | $0 (2022) |
| Mercedes Medical, LLC | $116.24 | 10 | $0 (2017) |
| NeoTract Inc. | $68.74 | 2 | $0 (2018) |
| Allergan, Inc. | $59.05 | 5 | $0 (2021) |
| Boston Scientific Corporation | $50.49 | 3 | $0 (2019) |
| Dendreon Pharmaceuticals LLC | $48.49 | 2 | $0 (2021) |
| Amgen Inc. | $48.15 | 2 | $0 (2019) |
| PFIZER INC. | $38.54 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $18.30 | 1 | ABBVIE INC. ($18.30) |
| 2021 | $232.61 | 14 | Astellas Pharma US Inc ($149.41) |
| 2020 | $1,506 | 16 | CIPLA USA INC. ($1,302) |
| 2019 | $365.78 | 24 | Astellas Pharma US Inc ($230.13) |
| 2018 | $483.23 | 32 | Astellas Pharma US Inc ($346.65) |
| 2017 | $657.03 | 51 | Astellas Pharma US Inc ($276.93) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/26/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: UROLOGY | ||||||
| 07/28/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: UROLOGY | ||||||
| 06/28/2021 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/07/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: ONCOLOGY | ||||||
| 05/19/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: ONCOLOGY | ||||||
| 05/05/2021 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/03/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/15/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: ONCOLOGY | ||||||
| 04/07/2021 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/31/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: ONCOLOGY | ||||||
| 03/09/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: ONCOLOGY | ||||||
| 02/10/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: ONCOLOGY | ||||||
| 01/13/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: ONCOLOGY | ||||||
| 01/11/2021 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/01/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: UROLOGY | ||||||
| 11/04/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: UROLOGY | ||||||
| 11/04/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $0.32 | General |
| Category: UROLOGY | ||||||
| 10/20/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $1.59 | General |
| Category: ONCOLOGY | ||||||
| 10/05/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: UROLOGY | ||||||
| 09/21/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: UROLOGY | ||||||
| 09/09/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/24/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 23 | 1,132 | 2,881 | $276,944 | $57,638 |
| 2020 | 30 | 2,011 | 4,662 | $556,161 | $109,371 |
Total Patients
3,143
Total Services
7,543
Medicare Billing
$167,009
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 185 | 229 | $59,311 | $18,187 | 30.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 16 | 96 | $96,000 | $16,371 | 17.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 102 | 108 | $18,900 | $4,846 | 25.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2021 | 144 | 148 | $10,360 | $2,722 | 26.3% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2021 | 12 | 12 | $7,800 | $2,423 | 31.1% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2021 | 17 | 17 | $18,275 | $2,278 | 12.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $7,543 | $1,914 | 25.4% |
| 55700 | Biopsy of prostate gland | Facility | 2021 | 21 | 21 | $11,235 | $1,911 | 17.0% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 20 | 20 | $11,100 | $1,155 | 10.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 268 | 364 | $7,644 | $1,148 | 15.0% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2021 | 41 | 52 | $3,640 | $956.28 | 26.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $4,180 | $913.42 | 21.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 92 | 103 | $5,150 | $704.23 | 13.7% |
| 76872 | Ultrasound of pelvic region through rectum | Facility | 2021 | 22 | 22 | $6,050 | $520.80 | 8.6% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 16 | 16 | $1,200 | $355.88 | 29.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 28 | $1,400 | $309.96 | 22.1% |
| 74018 | X-ray of abdomen, 1 view | Office | 2021 | 11 | 16 | $1,056 | $302.51 | 28.6% |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | Office | 2021 | 50 | 63 | $630.00 | $189.00 | 30.0% |
| J3260 | Injection, tobramycin sulfate, up to 80 mg | Office | 2021 | 14 | 38 | $570.00 | $147.90 | 25.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2021 | 14 | 1,400 | $2,100 | $127.20 | 6.1% |
| 82565 | Blood creatinine level | Office | 2021 | 15 | 15 | $300.00 | $76.80 | 25.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 15 | 15 | $120.00 | $49.20 | 41.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2021 | 12 | 68 | $2,380 | $29.39 | 1.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 22 | 199 | $199,000 | $34,627 | 17.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 204 | 242 | $62,678 | $18,305 | 29.2% |
About Dr. Gary Brown, MD
Dr. Gary Brown, MD is a Urology healthcare provider based in Amarillo, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1871584128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Brown, MD has received a total of $3,263 in payments from pharmaceutical and medical device companies, with $18.30 received in 2022. These payments were reported across 138 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,147).
As a Medicare-enrolled provider, Brown has provided services to 3,143 Medicare beneficiaries, totaling 7,543 services with total Medicare billing of $167,009. Data is available for 2 years (2020–2021), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Amarillo, TX
- Active Since 11/03/2005
- Last Updated 02/01/2026
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1871584128
Products in Payments
- ZEMDRI (PLAZOMICIN) (Drug) $1,302
- XTANDI (Drug) $411.49
- MYRBETRIQ (Drug) $337.66
- Myrbetriq (Drug) $276.93
- VESICARE (Drug) $152.93
- BOTOX (Biological) $65.62
- Androgel (Drug) $65.57
- Lupron (Drug) $55.71
- Urolift - UL400 (Device) $54.92
- 12mm Flanged Plug Cap Clear (Device) $50.00
- Stain Eosin-Y Phloxine 1GL (HAZ) (Device) $50.00
- PROVENGE (Drug) $48.49
- LUPRON DEPOT (Drug) $48.15
- JEVTANA (Drug) $38.38
- LITHOVUE (Device) $36.75
- XIAFLEX (Biological) $27.50
- XGEVA (Biological) $27.06
- Prolia (Biological) $21.09
- OSTOMY CARE (Device) $15.56
- Urgent PC (Device) $15.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Amarillo
Natalie Gaines, M.d, M.D
Urology — Payments: $14,063
Urology $14,063
Charles Teeple, Md, MD
Urology — Payments: $10,909
Urology $10,909
Richard Kibbey, Md, MD
Urology — Payments: $6,995
Urology $6,995
James Lemert, M.d, M.D
Urology — Payments: $6,426
Urology $6,426
Ronald Ford, Md, MD
Urology — Payments: $6,142
Urology $6,142
David Wilhelm, Md, MD
Urology — Payments: $6,057
Urology $6,057